Form 4: Surmodics Inc. Executive John Manders Reports Stock Transaction

John Manders, VP Finance and Corporate Controller at Surmodics Inc., reported the disposal of 387 shares of common stock to cover tax obligations.

Summary

• John Manders, a VP Finance and Corporate Controller at Surmodics Inc., filed a Form 4 indicating a transaction involving the company's common stock.
• On November 30, 2024, Mr. Manders disposed of 387 shares of common stock at a price of $39.45 per share.
• This transaction was to cover tax obligations related to the vesting of shares.
• Following the transaction, Mr. Manders beneficially owns 8,307 shares of Surmodics Inc. common stock.
• The report also notes that Mr. Manders acquired 179 shares through the Employee Stock Purchase Plan for the phase ending February 29, 2024, and 196 shares for the phase ending August 31, 2024.

Sentiment

Score: 5

Explanation: The document is neutral, reporting a routine stock transaction by an executive. There is no indication of positive or negative sentiment.

Positives

• The report shows that Mr. Manders participates in the Employee Stock Purchase Plan, indicating alignment with company success.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, as mandated by the SEC.
• The transaction is typical for executives who receive stock-based compensation and need to cover tax obligations.
• The number of shares disposed of is relatively small compared to the total shares owned by the executive.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale of shares by an executive.

Key Dates

Keywords

Surmodics Inc, SRDX, Form 4, insider trading, stock transaction, John Manders, employee stock purchase plan, tax obligations